Cargando…
A glimpse into the future of esophageal carcinoma in the United States: predicting the future incidence until 2040 based on the current epidemiological data
BACKGROUND: Esophageal carcinoma is the sixth most common cause of death worldwide. With the changing paradigm of esophageal carcinoma, we sought to estimate the future burden of esophageal carcinoma by histology, age, sex, and race, which could help plan prevention, control, and treatment strategie...
Autores principales: | Tella, Sri Harsha, Mara, Kristin, Chakrabarti, Sakti, Jin, Zhaohui, Mahipal, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007944/ https://www.ncbi.nlm.nih.gov/pubmed/36915445 http://dx.doi.org/10.21037/jgo-22-729 |
Ejemplares similares
-
Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions
por: Chakrabarti, Sakti, et al.
Publicado: (2020) -
Future number of people with diagnosed type 1 diabetes in Germany until 2040: an analysis based on claims data
por: Voeltz, Dina, et al.
Publicado: (2023) -
Projections of primary hip arthroplasty in Germany until 2040
por: Pilz, Veronika, et al.
Publicado: (2018) -
Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date
por: Tella, Sri Harsha, et al.
Publicado: (2019) -
First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination
por: Tella, Sri Harsha, et al.
Publicado: (2022)